Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Tondini, Carlo"'
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer.
Autor:
O'Regan RM; University of Rochester Department of Medicine, Rochester, New York., Zhang Y; Biotheranostics, A Hologic Company, San Diego, California., Fleming GF; The University of Chicago Medical Center, Chicago, Illinois., Francis PA; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia.; St Vincent's Hospital, Melbourne, Australia.; Breast Cancer Trials Australia & New Zealand, Newcastle, Australia.; University of Newcastle, Callaghan, Newcastle, Australia., Kammler R; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland., Viale G; International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology IRCCS, Milan, Italy.; Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy., Dell'Orto P; Department of Pathology and Laboratory Medicine, European Institute of Oncology IRCCS, Milan, Italy., Lang I; Clinexpert-Research, Budapest, Hungary., Bellet M; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain., Bonnefoi HR; Institut Bergonie Comprehensive Cancer Center, Universite de Bordeaux, INSERM U1312, Bordeaux, France.; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Tondini C; Ospedale Papa Giovanni XXIII, Bergamo, Italy., Villa F; Oncology Unit, Department of Oncology, Alessandro Manzoni Hospital, ASST Lecco, Lecco, Italy., Bernardo A; Operative Unit of Medical Oncology, IRCCS ICS Maugeri, Pavia, Italy., Ciruelos EM; SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain.; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain., Neven P; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Gynecologic Oncology and Multidisciplinary Breast Center, University Hospitals UZ Leuven, KU Leuven, Leuven, Belgium., Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Müller B; Chilean Cooperative Group for Oncologic Research (GOCCHI), Santiago, Chile., Jochum W; Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland., Zaman K; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.; Breast Center, Lausanne University Hospital CHUV, Lausanne, Switzerland., Martino S; The Angeles Clinic and Research Institute, Santa Monica, California.; SWOG Cancer Research Network, San Antonio, Texas., Geyer CE Jr; University of Pittsburgh Medical Center Hillman Cancer Center Pittsburgh, Pennsylvania.; NSABP Foundation/NRG Oncology, Pittsburgh, Pennsylvania., Jerzak KJ; Division of Medical Oncology, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada., Davidson NE; Fred Hutchinson Cancer Center, University of Washington Seattle, Washington.; ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania., Coleman RE; Weston Park Hospital, Sheffield, United Kingdom.; National Cancer Research Institute, Breast Cancer Clinical Studies Group (NCRI-BCSG), London, United Kingdom.; The Institute for Cancer Research, The Clinical Trials and Statistics Unit (ICR-CTSU), London, United Kingdom., Ingle JN; Mayo Clinic and Alliance for Clinical Trials in Oncology, Rochester, Minnesota., van Mackelenbergh MT; German Breast Group, Neu Isenburg, Germany.; University Hospital of Schleswig-Holstein, Campus Kiel, Germany., Loi S; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Cancer Research, Peter MacCallum Cancer Center, Melbourne Australia., Colleoni M; International Breast Cancer Study Group, ETOP IBCSG Partners Foundation, Bern, Switzerland.; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Schnabel CA; Biotheranostics, A Hologic Company, San Diego, California., Treuner K; Biotheranostics, A Hologic Company, San Diego, California., Regan MM; IBCSG Statistical Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Aug 15. Date of Electronic Publication: 2024 Aug 15.
Autor:
Licata L; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy. licata.luca@hsr.it.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy. licata.luca@hsr.it., De Sanctis R; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Medical Oncology and Hematology Unit, IRCCS - Humanitas Research Hospital, Rozzano, Milan, Italy., Vingiani A; Deparment of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; School of Medicine, University of Milan, Milan, Italy., Cosentini D; Medical Oncology Unit, ASST Spedali Civili of Brescia, Brescia, Italy., Iorfida M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Caremoli ER; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Sassi I; Pathology Unit, IRCCS Ospedale San Raffaele, Milan, Italy., Fernandes B; Department of Pathology, IRCCS - Humanitas Research Hospital, Rozzano - Milan, Italy., Gianatti A; Department of Pathology, ASST Papa Giovanni XXIII, Bergamo, Italy., Guerini-Rocco E; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Zambelli C; Pathology Unit, ASST Spedali Civili of Brescia, Brescia, Italy., Munzone E; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Simoncini EL; SSVD Breast Unit, ASST Spedali Civili of Brescia, Brescia, Italy., Tondini C; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Gentilini OD; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.; Breast Surgery Unit, San Raffaele Hospital, Milan, Italy., Zambelli A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Medical Oncology and Hematology Unit, IRCCS - Humanitas Research Hospital, Rozzano, Milan, Italy., Pruneri G; Deparment of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; School of Medicine, University of Milan, Milan, Italy., Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 May; Vol. 205 (1), pp. 39-48. Date of Electronic Publication: 2024 Jan 24.
Autor:
Mostaghim A; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, USA; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, USA., Minkove S; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, USA., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Ruiz-Camps I; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Eremiev-Eremiev S; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Dettorre GM; Department of Internal Medicine, Washington University School of Medicine, St. Louis, USA., Fox L; Department of Hematology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Tondini C; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Carmona-García M; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Lambertini M; Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Newsom-Davis T; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Sharkey R; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Pria AD; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Rossi M; Oncology Unit, Azienda Ospedaliera 'SS Antonio e Biagio e Cesare Arrigo', Alessandria, Italy., Plaja A; Medical Oncology Department, B-ARGO Group, IGTP, Catalan Institute of Oncology-Badalona, Spain., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Barcelona, Spain., Sureda A; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Michalarea V; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Van Hemelrijck M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Rimassa L; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, Milan, Italy., Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Pedrazzoli P; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy., Lee AJ; Cancer Division, University College London Hospital, London, UK., Murphy C; Cancer Division, University College London Hospital, London, UK., Belessiotis K; Cancer Division, University College London Hospital, London, UK., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, UK., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Pommeret F; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Stoclin A; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Martinez-Vila C; Fundació Althaia Manresa, Manresa, Spain., Bruna R; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Ospedale Maggiore della Carità Hospital, Novara, Italy., Gaidano G; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Ospedale Maggiore della Carità Hospital, Novara, Italy., D'Avanzo F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Athale J; Critical Care Medicine, Mayo Clinic Arizona, Phoenix, USA., Eichacker P; Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, USA., Pinato DJ; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, London, UK., Torabi-Parizi P; Critical Care Medicine Department, Clinical Center and National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892., Cortellini A; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, London, UK; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Roma, Italy. Electronic address: a.cortellini@imperial.ac.uk.
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Feb; Vol. 139, pp. 13-20. Date of Electronic Publication: 2023 Nov 27.
Autor:
Vincenzi B; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Cortellini A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, Du Cane Road, London, UK., Mazzocca A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Orlando S; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Romandini D; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Ruiz-Camps I; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Valverde Morales C; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain., Eremiev-Eremiev S; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Tondini C; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Bertulli R; Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Provenzano S; Medical Oncology 2, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK., Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Italy., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Spain., Sureda A; Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Vasiliki M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Van Hemelrijck M; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Jackson A; Velindre Cancer Centre, Cardiff, UK., Grosso F; Mesothelioma Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Lee AJX; Cancer Division, University College London Hospital, London, UK., Murphy C; Cancer Division, University College London Hospital, London, UK., Belessiotis K; Cancer Division, University College London Hospital, London, UK., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK., Pommeret F; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Loizidou A; Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Gaidano G; Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Ospedale Maggiore della Carità Hospital, Novara, Italy., Dettorre GM; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA., Grisanti S; Medical Oncology Unit, Spedali Civili, Brescia, Italy., Tucci M; Section of Medical Oncology, Department of Interdisciplinary Medicine (DIM), University of Bari 'Aldo Moro', Bari, Italy.; IRCCS, Istituto Tumori Giovanni Paolo II, Bari, Italy., Fulgenzi CAM; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy.; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, London, UK., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Napolitano A; The Royal Marsden NHS Foundation Trust, London, UK., Pinato DJ; Department of Surgery and Cancer, Imperial College of London, Hammersmith Hospital Campus, London, UK.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2024 Jan 18; Vol. 16, pp. 17588359231225028. Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2024).
Autor:
Miglietta F; Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padova, Italy., Dieci MV; Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padova, Italy. Electronic address: mariavittoria@unipd.it., Giarratano T; Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Torri V; Istituto Di Ricerche Farmacologiche Mario Negri - IRCCS, Milan, Italy., Giuliano M; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy., Zustovich F; Oncology, Ospedale di Belluno, Belluno, Italy., Mion M; UOC Oncologia, Camposampiero-Cittadella, AULSS6 Camposampiero, Italy., Tondini CA; Medical Oncology Department, ASST Papa Giovanni XXIII, Bergamo, Italy., De Rossi C; Medical Oncology Department, ULSS 3 Serenissima, Angel Hospital (Ospedale Dell'Angelo), Mestre and SS Giovanni e Paolo General Hospital, Venezia, Italy., Bria E; Medical Oncology, Università Cattolica del Sacro Cuore, Rome, Italy; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS Rome, Italy., Franchi M; Oncology, FROM Fondazione per la Ricerca Ospedale Maggiore, Bergamo, Italy., Merlini L; UOC Oncologia Ospedali Riuniti Padova Sud, Padova, Italy., Giannatiempo R; UOD di Anatomia Patologica, Ospedale Evangelico Betania, Napoli, Italy., Russo D; Unit of Pathology, Department of Advanced Biomedical Sciences, University of Naples Federico II, Napoli, Italy., Fotia V; Medical Oncology Department, ASST Papa Giovanni XXIII, Bergamo, Italy., Poletti P; Medical Oncology Department, ASST Papa Giovanni XXIII, Bergamo, Italy., Caremoli ER; Medical Oncology Department, ASST Papa Giovanni XXIII, Bergamo, Italy., Arpino MG; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy., De Salvo GL; Unità di ricerca clinica, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Zambelli A; Medical Oncology Unit, Humanitas Cancer Center - IRCCS, Rozzano, Milano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milano), Italy., Guarneri V; Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padova, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Dec; Vol. 195, pp. 113399. Date of Electronic Publication: 2023 Oct 26.
Autor:
Anpalakhan S; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., Signori A; University of Genoa, Genoa, Italy., Cortellini A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Roma, Italy.; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, UK., Verzoni E; SS. Oncologia Genitourinaria, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Giusti R; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Sant'Andrea, Roma, Italy., Aprile G; Department of Oncology, San Bortolo General Hospital, Unità Locale Socio-Sanitaria (ULSS) 8 Berica-East District, Vicenza, Italy., Ermacora P; Department of Oncology, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Azienda Sanitaria Universitaria Integrata Friuli Centrale, Udine, Italy., Catino A; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Pipitone S; Department of Oncology and Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero Universitaria of Modena, Modena, Italy., Di Napoli M; Oncologia Medica Uro-Ginecologica, Istituto Nazionale Tumori 'Fondazione G. Pascale,' IRCCS, Napoli, Italy., Scotti V; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy., Mazzoni F; Medical Oncology Unit, Oncology Department, Careggi University Hospital, Firenze, Italy., Guglielmini PF; S.C. Oncologia, AO SS Antonio e Biagio e C. Arrigo, Alessandria, Italy., Veccia A; Medical Oncology, Santa Chiara Hospital, Trento, Italy., Maruzzo M; Oncologia Medica 1, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Schinzari G; Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Casadei C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Grossi F; Medical Oncology Division, University of Insubria, ASST dei Sette Laghi, Varese, Italy., Rizzo M; Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia, Italy.; Medical Oncology Unit, Azienda Ospesaliera Universitaria Consorziale - Policlinico di Bari, Bari, Italy., Montesarchio V; U.O.C. Oncologia, Azienda Ospedaliera Specialistica dei Colli, Ospedale Monaldi, Napoli, Italy., Verderame F; Oncology Unit AO Azienda Ospedaliera Ospedali Riuniti 'Villa Sofia - Cervello', Palermo, Italy., Mencoboni M; Oncologia Medica, Ospedale Villa Scassi, Genova, Italy., Zustovich F; UOC Oncologia di Belluno, Dipartimento di Oncologia Clinica, AULSS 1 Dolomiti, Ospedale S.Martino, Belluno, Italy., Fratino L; Medical Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Pordenone, Italy., Accettura C; Medical Oncology Unit, Ospedale Vito Fazzi, Lecce, Italy., Cinieri S; Medical Oncology Division and Breast Unit, Senatore Antonio Perrino Hospital, ASL Brindisi, Brindisi, Italy., Tondini CA; Oncologia Medica, Ospedale Papa Giovanni XXIII, Bergamo, Italy., Camerini A; Oncologia Medica, Ospedale della Versilia, Lido di Camaiore, Italy., Banzi MC; Medical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Sorarù M; Medical Oncology, Camposampiero Hospital, Camposampiero (Padua), Italy., Zucali PA; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Department of Oncology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Vignani F; Department of Oncology, University of Turin, Turin, Italy.; Medical Oncology, AO Ordine Mauriziano, Turin, Italy., Ricciardi S; Pulmonary Oncology Unit, San Camillo-Forlanini Hospital, Rome, Italy., Russo A; Dipartimento di Discipline Chirurgiche, Oncologiche e Stomatologiche, Università degli Studi di Palermo, Palermo, Italy., Cosenza A; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Di Maio M; Department of Oncology, University of Turin, Turin, Italy.; Medical Oncology, AO Ordine Mauriziano, Turin, Italy., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Pignata S; Oncologia Medica Uro-Ginecologica, Istituto Nazionale Tumori 'Fondazione G. Pascale,' IRCCS, Napoli, Italy., Giannarelli D; Facility of Epidemiology & Biostatistics, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy., Pinto C; Medical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy., Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Rebuzzi SE; Medical Oncology Unit, Ospedale San Paolo, 17100 Savona, Italy.; Department of Internal Medicine and Medical Specialties (Di. M. I.), University of Genoa, Genoa, Italy., Rescigno P; Translational and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK., Addeo A; University Hospital Geneva, Geneva, Switzerland., Banna GL; Portsmouth Hospitals University NHS Trust, Portsmouth, UK.; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK., Bersanelli M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Federation of Italian Cooperative Oncology Groups (FICOG), Milan, Italy.
Publikováno v:
IScience [iScience] 2023 Sep 22; Vol. 26 (11), pp. 107970. Date of Electronic Publication: 2023 Sep 22 (Print Publication: 2023).
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.
Autor:
Gomez-Rosas P; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC+), 6229 ER Maastricht, The Netherlands.; Hospital de Oncologia, Unidad Medica de Alta Especialidad (UMAE), Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City 06720, Mexico., Giaccherini C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy., Russo L; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy., Verzeroli C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy., Gamba S; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy., Tartari CJ; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy., Bolognini S; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy., Ticozzi C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy., Schieppati F; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy., Barcella L; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy., Sarmiento R; Oncology Unit, Hospital San Filippo Neri, 00135 Rome, Italy., Masci G; Oncology Unit, IRCCS Humanitas Institute, 20089 Rozzano, Italy., Tondini C; Oncology Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy., Petrelli F; Oncology Unit, Hospital Treviglio-Caravaggio, 24047 Treviglio, Italy., Giuliani F; Oncology Unit, IRCCS Cancer Institute Giovanni Paolo II, 70124 Bari, Italy., D'Alessio A; Medical Oncology and Internal Medicine, Policlinico San Marco, Gruppo San Donato Zingonia-Bergamo, 24046 Zingonia, Italy., Minelli M; Oncology Unit, Hospital San Giovanni Addolorata, 00184 Rome, Italy., De Braud F; Oncology Unit, IRCCS National Cancer Institute, 20133 Milan, Italy., Santoro A; Oncology Unit, IRCCS Humanitas Institute, 20089 Rozzano, Italy., Labianca R; Fondazione ARTET Onlus, 24121 Bergamo, Italy., Gasparini G; Oncology Unit, Hospital San Filippo Neri, 00135 Rome, Italy., Marchetti M; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.; School of Medicine and Surgery, University of Milan Bicocca, 20126 Milan, Italy., Falanga A; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, 24127 Bergamo, Italy.; School of Medicine and Surgery, University of Milan Bicocca, 20126 Milan, Italy., On Behalf Of The Hypercan Investigators
Publikováno v:
Cancers [Cancers (Basel)] 2023 Sep 15; Vol. 15 (18). Date of Electronic Publication: 2023 Sep 15.
Autor:
Verzeroli C; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy., Giaccherini C; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy., Russo L; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy., Bolognini S; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy., Gamba S; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy., Tartari CJ; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy., Schieppati F; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy., Ticozzi C; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy., Vignoli A; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy., Masci G; Oncology Unit, Istituti di Ricovero e Cura a Carattere Scientifico Humanitas Institute, Rozzano, Italy., Sarmiento R; Oncology Unit, Hospital San Filippo Neri, Rome, Italy., Spinelli D; Department of Statistics, University of Milan Bicocca, Milan, Italy., Malighetti P; Department of Management Engineering, University of Bergamo, Italy., Tondini C; Oncology Unit, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy., Petrelli F; Oncology Unit, Hospital Treviglio-Caravaggio, Treviglio, Italy., Giuliani F; Oncology Unit, Istituti di Ricovero e Cura a Carattere Scientifico Cancer Institute Giovanni Paolo II, Bari, Italy., D'Alessio A; Medical Oncology and Internal Medicine, Policlinico San Marco, Gruppo San Donato Zingonia-Bergamo, Italy., Gasparini G; Oncology Unit, Hospital San Filippo Neri, Rome, Italy., Minelli M; Oncology Unit, Hospital San Giovanni Addolorata, Rome, Italy., De Braud F; Oncology Unit, Istituti di Ricovero e Cura a Carattere Scientifico National Cancer Institute, Milan, Italy., Santoro A; Oncology Unit, Istituti di Ricovero e Cura a Carattere Scientifico Humanitas Institute, Rozzano, Italy., Labianca R; Fondazione ARTET, Bergamo, Italy., Marchetti M; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy; University of Milan Bicocca, School of Medicine, Milan, Italy., Falanga A; Immunohematology and Transfusion Medicine, Aziende Socio Sanitarie Territoriali Hospital Papa Giovanni XXIII, Bergamo, Italy; University of Milan Bicocca, School of Medicine, Milan, Italy. Electronic address: annafalanga@yahoo.com.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2023 Jul; Vol. 21 (7), pp. 1869-1881. Date of Electronic Publication: 2023 Apr 11.
Autor:
Tagliamento M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy., Gennari A; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Salazar R; Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Barcelona, Spain., Harbeck N; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany., Del Mastro L; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Medical Oncology Department, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Aguilar-Company J; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain., Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Sharkey R; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Dalla Pria A; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom., Plaja A; Medical Oncology Department, B-ARGO Group, IGTP, Catalan Institute of Oncology-Badalona, Badalona, Spain., Jackson A; Velindre Cancer Centre, Cardiff, United Kingdom., Handford J; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., Sita-Lumsden A; Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, United Kingdom., Martinez-Vila C; Fundació Althaia Manresa, Manresa, Spain., Matas M; Fundació Althaia Manresa, Manresa, Spain., Miguel Rodriguez A; Fundació Althaia Manresa, Manresa, Spain., Vincenzi B; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Tonini G; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Bertuzzi A; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Brunet J; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain., Pedrazzoli P; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy., D'Avanzo F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Biello F; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Sinclair A; Cancer Division, University College London Hospitals, London, United Kingdom., Lee AJX; Cancer Division, University College London Hospitals, London, United Kingdom., Rossi S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Mirallas O; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Pimentel I; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain., Iglesias M; Hospital Son Llatzer Palma de Mallorca, Spain., Sanchez de Torre A; Hospital Universitario XII de Octubre Madrid, Spain., Guida A; Department of Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy., Berardi R; Medical Oncology, AOU Ospedali Riuniti, Polytechnic University of the Marche Region, Ancona, Italy., Zambelli A; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Tondini C; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Filetti M; Medical Oncology, St Andrea Hospital, Rome, Italy., Mazzoni F; Medical Oncology, Careggi University Hospital, Florence, Italy., Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, United Kingdom., Diamantis N; Medical Oncology, Barts Health NHS Trust, London, United Kingdom., Parisi A; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy., Aujayeb A; Respiratory Department, Northumbria Healthcare NHS Foundation Trust, North Shields, United Kingdom., Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Libertini M; Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy., Grisanti S; Medical Oncology Unit, Spedali Civili, Brescia, Italy., Rossi M; Oncology Unit, Azienda Ospedaliera 'SS Antonio e Biagio e Cesare Arrigo,' Alessandria, Italy., Zoratto F; Santa Maria Goretti Hospital, Latina, Italy., Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Cremona, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Saura C; Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain., Lyman GH; Public Health Sciences Division and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington School of Medicine, Seattle, WA.; Divisions of Public Health Science and Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA., Kuderer NM; Advanced Cancer Research Group, Seattle, WA., Pinato DJ; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Cortellini A; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 May 20; Vol. 41 (15), pp. 2800-2814. Date of Electronic Publication: 2023 Jan 31.
Autor:
Licata L; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Cosentini D; Medical Oncology Unit, ASST Spedali Civili of Brescia, Brescia, Italy., De Sanctis R; Medical Oncology and Hematology Unit, IRCCS - Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Iorfida M; Division of Medical Senology, IEO, European Institute of Oncology, Milan, Italy., Caremoli ER; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Vingiani A; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Faculty of Medicine and Surgery, University of Milan, Milan, Italy., Simoncini EL; SSVD Breast Unit, ASST Spedali Civili of Brescia, Brescia, Milan, Italy., Pruneri G; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Faculty of Medicine and Surgery, University of Milan, Milan, Italy., Munzone E; Division of Medical Senology, IEO, European Institute of Oncology, Milan, Italy., Bianchini G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Zambelli A; Medical Oncology and Hematology Unit, IRCCS - Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Tondini C; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Mar 06; Vol. 13, pp. 1081885. Date of Electronic Publication: 2023 Mar 06 (Print Publication: 2023).